Case Study Interviewees (State Agencies and DSNPs) Arizona Arizona Health Care Cost Containment System Bridgeway Health Solutions (Centene) Mercy Care Advantage UnitedHealthcare University Care Advantage Massachusetts Massachusetts Executive Office of Health and Human Services Commonwealth Care Alliance Senior Whole Health Tufts Health Plan UnitedHealthcare Minnesota Minnesota Department of Human Services HealthPartners PrimeWest UCare New Jersey New Jersey Department of Human Services AmeriGroup New Jersey HealthFirst Health Plan UnitedHealthcare Tennessee Bureau of TennCare AmeriGroup Tennessee BlueCare Tennessee UnitedHealthcare In-Person Meeting Attendees Arizona : Tom Betlach, Director, Arizona Health Care Cost Containment System Massachusetts : Susan Ciccariello, Assistant Director for Coordinated Care, Massachusetts Executive Office of Health and Human Services Minnesota : Sue Kvendru, Special Needs Purchasing Coordinator and Gretchen Ulbee, Special Needs Purchasing Manager, Minnesota Department of Human Services New Jersey : Elizabeth Wood, Director of Dual Integration, New Jersey Department of Human Services New Mexico : Tallie Tolen, Long-Term Services and Supports Bureau Chief, New Mexico Human Services Department Pennsylvania : Kevin Hancock, Chief of Staff, Office of Long-Term Living, Pennsylvania Department of Human Services Tennessee : Patti Killingsworth, Assistant Commissioner and Chief of Long-Term Services and Supports, Tennessee Bureau of TennCare Texas : Juliet Charron, Senior Advisor, Texas Health and Human Services Commission Virginia : Karen Kimsey, Deputy Director for Complex Care Service and Tammy Whitlock, Division Director for Integrated Care and Behavioral Services, Virginia Department of Medical Assistance Services Wisconsin : Curtis Cunningham, Administrator, Division of Long-Term Care, Wisconsin Department of Health Services APPENDIX C
Includes a wellresearched peptide (GHKCu) at a potent dose (1%)
Preparedness encompasses allowing for earlier treatment and care, general planning for the future, encouraging action to preserve cognitive function for as long as possible, addressing safety issues in advance, and assembling medical and caregiving teams
The preclinical data place GHK-Cus influence primarily in the proliferation and remodeling phases recruiting and activating fibroblasts, feeding matrix synthesis, supporting new-vessel formation to perfuse the growing tissue, and then enabling proper cross-linking so the new matrix gains strength
